This document was printed from the website of the California Evidence-Based Clearinghouse for Child Welfare (CEBC), which you can access at http://www.cachildwelfareclearinghouse.org/
This document was printed from the website of the California Evidence-Based Clearinghouse for Child Welfare (CEBC), which you can access at http://www.cachildwelfareclearinghouse.org/
Note: The Neurosequential Model of Therapeutics (NMT) program was not responsive to the CEBC's request for information about their program. The following information was obtained from publicly available sources (websites, articles, etc.).
Scientific Rating:
4
Lacks Adequate Research Evidence
See scale of 1-6
Relevance to Child Welfare Rating:
1
High
See scale of 1-3
Brief Description:
The Neurosequential Model of Therapeutics (NMT) has been rated by the CEBC in the area of Trauma Treatment for Children. The Neurosequential Model of Therapeutics (NMT) is a developmentally informed, biologically respectful approach to working with at-risk children. This clinical approach helps professionals determine the strengths and vulnerabilities of a given child and create individualized intervention, enrichment, and educational plans for children. The goal is to find the appropriate set of therapeutic activities that match a child's current need in various domains of functioning (i.e., social, emotional, cognitive and physical). Patterned, repetitive, and developmentally appropriate activities are provided in context of nurturing relationships. Active participation of caregivers and other adults in the child's life is important to the success of the NMT; by weaving various activities throughout the child's various relationships and environments, the majority of "therapeutic" experiences are provided outside of the actual context of conventional therapy. The model has three key components - assessment, staffing/training, and the array of therapeutic, educational, and enrichment activities.
Manual and Training section:
The publicly available information indicates that there is a manual and some training available for the Neurosequential Model of Therapeutics (NMT), please contact Jana Lihn Rosenfelt at JLRosenfelt@ChildTraumaAcademy.org or 281-932-1375. A detailed description of the certification process can be found at: www.childtrauma.org-ctaServices-NMT_CertificationProcess_08.pdf.
Relevant Published, Peer-Reviewed Research:
Neurosequential Model of Therapeutics (NMT) is rated a "4 - Lacks Adequate Research Evidence" on the Scientific Rating Scale because it lacks published, peer-reviewed research that meets the CEBC criteria for a scientific rating of a 3, 2, or 1; however it was identified by the topic expert as a program being used in the field, or it is being marketed and/or used in California with children receiving services from child welfare or related systems and their parents/caregivers. Some programs rated a 4 may have some published, peer-reviewed research that does not meet the above stated criteria or may have other studies that have not yet been published in the peer-reviewed literature. For more information on the rating of a "4 - Lacks Adequate Research Evidence," please see the Scientific Rating Scale.
There are currently no published, peer-reviewed research studies for Neurosequential Model of Therapeutics (NMT).
References:
Perry, B.D. (2006). Applying principles of neurodevelopment to clinical work with maltreated and traumatized children. In N. Boyd Webb, (Ed.), Working with traumatized children in child welfare. New York, NY: The Guilford Press:
Barfield, S., & Gaskill, R. (2005). Positive impact of the Neurosequential Model of Therapeutics in high-risk children in a therapeutic preschool. Lawrence, KS: University Press of Kansas.
Contact Information
Name: Jana Lihn Rosenfelt
Affiliation/Agency: Child Trauma Academy
Phone: 281-932-1375
E-mail: JLRosenfelt@ChildTraumaAcademy.org
Website:www.childtraumaadademy.org
Date review compiled: June 2008